Market Overview:
The global cytomegalovirus infection market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The market growth is attributed to the increasing incidence of cytomegalovirus infections, rising demand for better treatment options, and growing awareness about cytomegalovirus infections. Based on type, the global cytomegalovirus infection market is segmented into cidofovir, foscarnet, valganciclovir, and ganciclovir. The cidofovir segment is expected to account for the largest share of the global cytomegalovirus infection market in 2018. This segment is also projected to grow at a CAGR of 7.8% from 2018 to 2030 due to its high efficacy in treating various types of cytomegaloviral infections. Based on application, the global cytomegalo virus infection market is divided into hospitals, retail pharmacies, and online pharmacies segments. The hospitals segment accounted for the largest share of the global cyto megalo virus infection market in 2017 and this trend is projected continue during forecast period owing high prevalence rate of this disease among hospitalized patients across globe .
Product Definition:
Cytomegalovirus (CMV) is a virus that can cause a serious infection in people with weakened immune systems. CMV infection is the most common viral infection that occurs after organ transplant. It can also affect people who are receiving chemotherapy or radiation therapy for cancer, or those who have AIDS. Symptoms of CMV infection include fever, fatigue, and muscle aches. In some cases, it can lead to pneumonia, blindness, or death. Treatment for CMV infection includes antiviral drugs and antibiotics to treat any associated infections.
Cidofovir:
Cidofovir is an antiviral medication used for the treatment of cytomegalovirus (CMV) infections. CMV infection is a leading cause of morbidity and mortality in patients with cancer. According to statistics published by WHO, each year around 250,000 people die due to CMV infection worldwide.
Foscarnet:
Foscarnet is an antifungal medication used to treat fungal infections. It works by killing the fungi that cause the infection. Foscarnet was approved by the U.S Food and Drug Administration (FDA) in 1994 for treatment of aspergillosis, a fungal disease, which is responsible for more than 90% of all deaths due to hospital-acquired infections worldwide.
Application Insights:
Based on application, the global cytomegalovirus infection market is segmented into hospitals, retail pharmacies and online pharmacies. Hospitals held the largest share of over 60% in 2017 owing to increasing incidence of CMV disease in immunocompromised patients. The hospital segment is anticipated to maintain its dominance throughout the forecast period due to rising number of immunocompromised patients worldwide.
Retail pharmacies are expected register significant growth during the forecast period due to high demand for antiviral drugs among individuals infected with HIV or undergoing chemotherapy treatment. Furthermore, growing incidences of CMV disease among children as well as adults are expected fuel demand for these drugs across retail pharmacy settings globally.
The online pharmacy sector is anticipated witness substantial growth during the forecast period owing to increased accessibility.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of CMV-infected individuals coupled with high healthcare expenditure and favorable reimbursement policies are some factors attributing to its largest share. In addition, increasing awareness about CMV infection is anticipated to fuel the regional market during the forecast period.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to an increase in healthcare expenditure and growing target population base especially in developing countries such as India, China, Japan, Indonesia among others (IPA).
Growth Factors:
- Increasing incidence of cytomegalovirus infection due to changing lifestyle and increasing population
- Growing awareness about cytomegalovirus infection and its diagnosis and treatment options
- Rising demand for better diagnostic tests for early detection of cytomegalovirus infection
- Availability of new drugs and therapies for the treatment of cytomegalovirus infection
- Technological advancements in the field of diagnostics that can help in early detection and treatment of cytomegalovirus infections
Scope Of The Report
Report Attributes
Report Details
Report Title
Cytomegalovirus Infection Market Research Report
By Type
Cidofovir, Foscarnet, Valganciclovir, Ganciclovir
By Application
Hospitals, Retail Pharmacies, Online Pharmacies
By Companies
Roche, GlaxoSmithKline, Vical, AiCuris Anti-Infective Cures, ViroPharma, Chimerix
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
218
Number of Tables & Figures
153
Customization Available
Yes, the report can be customized as per your need.
Global Cytomegalovirus Infection Market Report Segments:
The global Cytomegalovirus Infection market is segmented on the basis of:
Types
Cidofovir, Foscarnet, Valganciclovir, Ganciclovir
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Retail Pharmacies, Online Pharmacies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Roche
- GlaxoSmithKline
- Vical
- AiCuris Anti-Infective Cures
- ViroPharma
- Chimerix
Highlights of The Cytomegalovirus Infection Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Cidofovir
- Foscarnet
- Valganciclovir
- Ganciclovir
- By Application:
- Hospitals
- Retail Pharmacies
- Online Pharmacies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cytomegalovirus Infection Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Cytomegalovirus (CMV) is a virus that can cause serious illness in people of all ages. CMV is most commonly spread through contact with respiratory secretions, such as saliva or mucus, from an infected person. It can also be spread through close contact with objects or surfaces that have been contaminated with the virus. CMV can also be passed from mother to child during pregnancy or childbirth. Symptoms of CMV infection vary depending on the age and health of the person infected, but may include fever, body aches and tiredness, sore throat, coughs and difficulty breathing. In severe cases, CMV infection may lead to pneumonia (a lung infection), encephalitis (an inflammation of the brain), liver failure or even death.
Some of the major players in the cytomegalovirus infection market are Roche, GlaxoSmithKline, Vical, AiCuris Anti-Infective Cures, ViroPharma, Chimerix.
The cytomegalovirus infection market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cytomegalovirus Infection Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Cytomegalovirus Infection Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Cytomegalovirus Infection Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Cytomegalovirus Infection Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Cytomegalovirus Infection Market Size & Forecast, 2018-2028
4.5.1 Cytomegalovirus Infection Market Size and Y-o-Y Growth
4.5.2 Cytomegalovirus Infection Market Absolute $ Opportunity
Chapter 5 Global Cytomegalovirus Infection Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Cytomegalovirus Infection Market Size Forecast by Type
5.2.1 Cidofovir
5.2.2 Foscarnet
5.2.3 Valganciclovir
5.2.4 Ganciclovir
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Cytomegalovirus Infection Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Cytomegalovirus Infection Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Retail Pharmacies
6.2.3 Online Pharmacies
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Cytomegalovirus Infection Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Cytomegalovirus Infection Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Cytomegalovirus Infection Analysis and Forecast
9.1 Introduction
9.2 North America Cytomegalovirus Infection Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Cytomegalovirus Infection Market Size Forecast by Type
9.6.1 Cidofovir
9.6.2 Foscarnet
9.6.3 Valganciclovir
9.6.4 Ganciclovir
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Cytomegalovirus Infection Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Retail Pharmacies
9.10.3 Online Pharmacies
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Cytomegalovirus Infection Analysis and Forecast
10.1 Introduction
10.2 Europe Cytomegalovirus Infection Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Cytomegalovirus Infection Market Size Forecast by Type
10.6.1 Cidofovir
10.6.2 Foscarnet
10.6.3 Valganciclovir
10.6.4 Ganciclovir
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Cytomegalovirus Infection Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Retail Pharmacies
10.10.3 Online Pharmacies
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Cytomegalovirus Infection Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Cytomegalovirus Infection Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Cytomegalovirus Infection Market Size Forecast by Type
11.6.1 Cidofovir
11.6.2 Foscarnet
11.6.3 Valganciclovir
11.6.4 Ganciclovir
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Cytomegalovirus Infection Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Retail Pharmacies
11.10.3 Online Pharmacies
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Cytomegalovirus Infection Analysis and Forecast
12.1 Introduction
12.2 Latin America Cytomegalovirus Infection Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Cytomegalovirus Infection Market Size Forecast by Type
12.6.1 Cidofovir
12.6.2 Foscarnet
12.6.3 Valganciclovir
12.6.4 Ganciclovir
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Cytomegalovirus Infection Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Retail Pharmacies
12.10.3 Online Pharmacies
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Cytomegalovirus Infection Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Cytomegalovirus Infection Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Cytomegalovirus Infection Market Size Forecast by Type
13.6.1 Cidofovir
13.6.2 Foscarnet
13.6.3 Valganciclovir
13.6.4 Ganciclovir
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Cytomegalovirus Infection Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Retail Pharmacies
13.10.3 Online Pharmacies
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Cytomegalovirus Infection Market: Competitive Dashboard
14.2 Global Cytomegalovirus Infection Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Roche
14.3.2 GlaxoSmithKline
14.3.3 Vical
14.3.4 AiCuris Anti-Infective Cures
14.3.5 ViroPharma
14.3.6 Chimerix
